← back to search

Mitchell C. Posner

University of Chicago · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, Pancreatic and Hepatic Oncology Research, and Gastrointestinal Tumor Research and Treatment.
h-index
51
citations
11,193
works
363
NIH funding
primary concept
email

Recent publications

Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
JAMA Oncology 2023cited by 31position: middledoi
Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic
Journal of the American College of Surgeons 2020cited by 358position: middledoi
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
Cancer Discovery 2020cited by 66position: middledoi
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis
Proceedings of the National Academy of Sciences 2020cited by 51position: middledoi
Evaluation of the Association of Perioperative <i>UGT1A1</i> Genotype–Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma
JAMA Network Open 2020cited by 32position: lastdoi
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
Annals of Surgical Oncology 2019cited by 27position: lastdoi
Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer
Annals of Surgery 2018cited by 402position: middledoi
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
Nature Communications 2018cited by 249position: middledoi
DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs
Cancer Research 2018cited by 46position: middledoi
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung Cancers
Molecular Cancer Therapeutics 2018cited by 23position: middledoi
In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases
Molecular Therapy 2017cited by 47position: middledoi
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study
Journal of Surgical Oncology 2017cited by 30position: middledoi
Extremes of body mass index and postoperative complications after esophagectomy
Diseases of the Esophagus 2017cited by 29position: middledoi
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance
Oncotarget 2016cited by 69position: middledoi
Interdisciplinary Oncology Education: a National Survey of Trainees and Program Directors in the United States
Journal of Cancer Education 2016cited by 35position: middledoi
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers
Scientific Reports 2016cited by 22position: middledoi
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes
JAMA 2015cited by 1,089position: middledoi
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome
British Journal of Cancer 2015cited by 137position: middledoi
14q32-encoded microRNAs mediate an oligometastatic phenotype
Oncotarget 2015cited by 110position: middledoi
Doubling of 30-Day Mortality by 90 Days After Esophagectomy
Annals of Surgery 2015cited by 89position: middledoi
Treatment Trends, Risk of Lymph Node Metastasis, and Outcomes for Localized Esophageal Cancer
JNCI Journal of the National Cancer Institute 2014cited by 151position: middledoi
Cancer Recurrence: An Important but Missing Variable in National Cancer Registries
Annals of Surgical Oncology 2014cited by 103position: middledoi
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs
Clinical & Experimental Metastasis 2014cited by 80position: middledoi
Complete Endoscopic Mucosal Resection Is Effective and Durable Treatment for Barrett's-Associated Neoplasia
Clinical Gastroenterology and Hepatology 2014cited by 73position: middledoi
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma
Annals of Surgical Oncology 2014cited by 58position: lastdoi
Impact of Hepatectomy Surgical Complexity on Outcomes and Hospital Quality Rankings
Annals of Surgical Oncology 2014cited by 35position: middledoi
Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design
Annals of Surgical Oncology 2013cited by 337position: middledoi
Geriatric Assessment Improves Prediction of Surgical Outcomes in Older Adults Undergoing Pancreaticoduodenectomy
Annals of Surgery 2013cited by 157position: middledoi
Defining Surgical Quality in Gastric Cancer: A RAND/UCLA Appropriateness Study
Journal of the American College of Surgeons 2013cited by 45position: middledoi
Processes of Care in the Multidisciplinary Treatment of Gastric Cancer
JAMA Surgery 2013cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ralph R. Weichselbaum · University of Chicago Medical Center13 papers (2012–2023)Nikolai N. Khodarev · University of Chicago10 papers (2012–2020)Sean P. Pitroda · University of Chicago Medical Center7 papers (2015–2023)Mark K. Ferguson · Emory University6 papers (2012–2017)Melinda E. Stack · Colon and Rectal Surgery Associates5 papers (2015–2020)Sean C. Wightman · University of Southern California5 papers (2015–2018)Sabha Ganai · Los Angeles Medical Center5 papers (2012–2018)Abhineet Uppal · The University of Texas MD Anderson Cancer Center5 papers (2014–2018)Hedy L. Kindler · Public Health Ontario4 papers (2013–2020)Peter W. T. Pisters · Université Laval4 papers (2013–2019)Xiaona Huang · Guangzhou Medical University4 papers (2015–2018)Ryan P. Merkow · Chicago Department of Public Health4 papers (2013–2015)Karl Y. Bilimoria · Regenstrief Institute4 papers (2013–2014)Go Oshima · Eiju General Hospital4 papers (2015–2018)Marina Talamonti · Policlinico Tor Vergata4 papers (2014–2023)Samuel Hellmän · Public Health Agency of Sweden4 papers (2012–2018)David P. Winchester · Roswell Park Comprehensive Cancer Center3 papers (2013–2015)Kevin K. Roggin · University of Chicago3 papers (2013–2020)David J. Bentrem · Jesse Brown VA Medical Center3 papers (2013–2014)Haejin In · Rutgers, The State University of New Jersey3 papers (2014–2015)